Parkinson’s is one of the most common neurodegenerative diseases and continues to pose major challenges for neurology. It has long been clear that age is the decisive risk factor – but the mechanisms of how biological ageing and neuronal degeneration interact have so far been incompletely understood. In recent years, a cellular process has increasingly become the focus of research: senescence. It describes a state of irreversible cell cycle arrest, accompanied by profound metabolic changes and a pro-inflammatory secretion profile.
Autoren
- Tanja Schliebe
Publikation
- InFo NEUROLOGIE & PSYCHIATRIE
Related Topics
You May Also Like
Opicapon: double benefit for motor function and sleep in Parkinson’s disease
- Colorectal cancer
Is exercise better than medication?
- Itching in primary biliary cholangitis
When the skin becomes agony
- TREATswitzerland Register
Evaluation of system therapies for AD
- Cardiogenic shock - 2025 update
Between standardization, team processes and targeted cycle support
- Collagenoses
Scleroderma – Current recommendations for diagnosis and therapy 2025
- Multiple sclerosis
Avoiding the nocebo trap with natalizumab biosimilars
- COPD and comorbidities